Pro-life groups sound off after Trump says he will not restrict abortion pills: ‘serious and growing threat’

Pro-life leaders are speaking out against the dangers of chemical abortion pills after President-elect Trump stated that he would not restrict access to these pills once he takes office. Chemical abortion, also known as abortion pills, has become the most common method of abortion in the United States, accounting for over 60% of all abortions.

In a recent interview with NBC’s “Meet the Press,” Trump was asked whether he would consider restricting access to abortion pills through executive action. Trump responded firmly, saying, “the answer is no.” He reiterated his stance that abortion is a state, not a federal issue, and indicated that he would not interfere with access to these pills.

This decision has sparked concern among pro-life groups, who see the expansion of chemical abortion access as a threat to women’s health and safety. Marjorie Dannenfelser, president of Susan B. Anthony Pro-Life America, criticized the Biden administration for removing regulations that required in-person appointments for abortion pill administration. She pointed to recent deaths linked to abortion pill complications and emphasized the need to address this issue.

Kristan Hawkins, president of Students for Life Action, expressed optimism that Trump would recognize the dangers of unrestricted chemical abortion access. She highlighted the importance of providing new information about the risks associated with these pills and urged the new administration to take action to protect women.

Brian Burch, president of CatholicVote, echoed these concerns, calling for evidence-based regulations and oversight of abortion pills. He expressed hope that the Trump administration would prioritize women’s health and safety in addressing this issue.

Overall, pro-life leaders are urging the new administration to take a closer look at the impact of chemical abortion pills and to consider implementing measures to protect women and unborn children. The conversation surrounding this topic is ongoing, with a focus on promoting informed decision-making and ensuring the safety of those seeking abortion care.